Search results
1 sty 2015 · In order to comply with European legislation on protection of personal data (PPD), clinical reports must be anonymised to prevent patients and professionals who participated in clinical trials from being identified. This usually involves redacting personal data.
Individual participant data (IPD) reviews are a specific type of systematic review that involve the collection, checking and re-analysis of the original data for each participant in each study. Data may be obtained either from study investigators or via data-sharing repositories or platforms.
This test involves the intradermal injection of purified protein derivative (PPD) and the subsequent measurement of the induration (raised area) at the injection site. A properly formatted Mantoux test report is essential for communicating the results accurately and aiding in clinical decision-making.
Methods: report eligibility criteria; data sources including dates of last bibliographic search or elicitation, noting that IPD were sought; methods of assessing risk of bias. Results: provide number and type of studies and participants identified and number (%) obtained; summary effect estimates for
While IPD disclosure under Phase 2 of Policy 0070 may be some way off, achieving the balance of data utility and anonymisation is predicted to be much more challenging given the nature of IPD.
Results: Both methods proved to be effective for measuring the UVAPF. However, all the UVAPF values determined by the PPD method were lower than those determined by the IPD method. Additionally, an exponential relationship between the amount of sunscreen applied and the UVAPF was observed.
1 cze 2011 · Persistent pigment darkening (PPD) is a widely used in vivo method for measurement of ultraviolet (UV) A protection factor (UVAPF). However, with increased emphasis on UVA protection...
